• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

Pfizer, Inc.

NYSE:PFE

$22.13 -$0.01 (-0.05%)

REAL-TIME: Last trade at

Jump to this page for:

Related Resources

A Detailed Overview Of The Best Dogs Of The Dow Jones In May 2012

5/28/2012 by Seeking Alpha

Insurance For Health Care Stocks

5/28/2012 by Seeking Alpha

Billionaire Phillip Frost: A Case Study In Synergy

5/28/2012 by Trefis

Why the Dow Finished Higher This Week, and Facebook Didn't

5/26/2012 by DailyFinance

Have J&J's Approval Hopes Vanished?

5/26/2012 by DailyFinance

The Dow's 3 Biggest Losers This Week

5/26/2012 by DailyFinance

Wal-Mart And Death Of The Shareholder Spring: The Stock Story Of The Coming Week

5/26/2012 by Seeking Alpha

Abbott Wants To Extract More From Humira While Pfizer Slogs Along With Lipitor

5/25/2012 by Trefis

Emergent, Pfizer, Abbott Looking Strong In Their Fields

5/25/2012 by Trefis

Pfizer: A $22 Stock Worth $25

5/25/2012 by Seeking Alpha

Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 2

5/25/2012 by Seeking Alpha

Biogen Tysabri Canadian Label Update - Analyst Blog

5/25/2012 by Nasdaq

The Meaningless Drug Approval That Could Cost the Industry Billions

5/25/2012 by DailyFinance

Pfizer Drug for Rare Disease Shouldn't Be Approved, US Review Says [UPDATE]

5/25/2012 by Minyanville

Pfizer: Don't Overlook This $22 Gem

5/24/2012 by Seeking Alpha

Shorter Timeframe, More Risky

5/24/2012 by DailyFinance

Johnson & Johnson Setback Is Positive for Pfizer, Bristol-Myers

5/24/2012 by Minyanville

Abbott Aims Pediatric Nutritional Market With New Beverage

5/24/2012 by Trefis

Undervalued Leaders From Jeremy Grantham To Buy - Will You Let Them Pass By?

5/24/2012 by Seeking Alpha

FDA Panel: Data Could Support Approval Of Pfizer Drug Tafamidis

5/24/2012 by Smart Money

Major US Shares Start Trading On Chile's Main Stock Exchange

5/24/2012 by Smart Money

Hedge Funds' Top 10 Stocks: For This They Get Two-and-Twenty?

5/23/2012 by YCharts

Buy, Sell, or Hold: Johnson & Johnson

5/23/2012 by DailyFinance

WSJ BLOG/Health: A.M. Vitals: Anticipating the Health Law Ruling

5/23/2012 by Smart Money

Hide from Europe's mess with dividend stocks

5/23/2012 by CNN Money

JNJ Updates: Imodium Recalls; Heading For Chinese Acquisitions; Zytiga’s Success

5/23/2012 by Trefis

Is Bristol a Buy Post-Plavix

5/23/2012 by DailyFinance

Chelsea: A Short-Term Buying Opportunity

5/23/2012 by Seeking Alpha

Investing in Weight Loss Ahead of This Summer’s FDA Decisions

5/23/2012 by Trefis

FDA Reviewer Recommends Against Approval Of Pfizer Drug

5/22/2012 by Smart Money

Abbott Updates: Niaspan Losing Vigor, But Nutritionals Going Strong

5/22/2012 by Trefis

UPDATE: FDA Reviewer Recommends Against Approval Of Pfizer Drug

5/22/2012 by Smart Money

3 Dow Stocks That Held the Average Down

5/22/2012 by DailyFinance

Pfizer Drug for Rare Disease Shouldn't Be Approved, US Review Says

5/22/2012 by Minyanville

Shorts Are Piling Into These Stocks. Should You Be Worried?

5/21/2012 by DailyFinance

Pfizer Updates: Zithromax Associated With Heart Deaths; Xalcori Successful

5/21/2012 by Trefis

Johnson & Johnson's Xarelto Should Be Given to More Patients, FDA Staff Says

5/21/2012 by Minyanville

Will the Dow Break Its Losing Streak?

5/21/2012 by DailyFinance

Bristol-Myers Squibb's Thud Heard Round the World

5/20/2012 by DailyFinance

Pfizer Recalls More Than 650,000 Bottles Of Advil Liqui-Gels

5/18/2012 by Smart Money
See More Articles...